PTC Therapeutics, Inc. announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarnatm (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy ...
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarnaâ„¢ (ataluren) for the treatment of nonsense mutation Duchenne ...
Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers. The ...
Our current approach to mental health labelling and diagnosis has brought benefits. But as a practising doctor, I am concerned that it may be doing more harm than good ...
PBS NC helps your community explore new worlds and ideas through programs that educate, inform and inspire. Your ...
The registrations for NEET 2026 have commenced. In order to appear for the MBBS entrance test, the candidates need to be well aware of the syllabus for the test. The National ...
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
My Investing News on MSN
9 healthcare stocks that are complete dogs
Key Points The healthcare sector has chronically underperformed in the past few years, trailing S&P 500 performance by a wide ...
Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint ...
For many people, spotting blood in the urine is often the first warning sign of bladder cancer. But for those with color ...
Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...
New partner leadership to help deepen relationships with data, orchestration, and core platform providers embedded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results